Outlook Therapeutics- Warrants Overview

Outlook Therapeutics- Warrants Cost of Revenue

Cost of Revenue analysis for OTLKW.

Quarterly Cost of Revenue

$149.33B

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$1505.66B

↑ 1323840642.43% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin